These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15548708

  • 21. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [Abstract] [Full Text] [Related]

  • 22. Knockdown of survivin expression by small interfering RNA induces apoptosis in human breast carcinoma cell line MCF-7.
    Li JX, Zhou KY, Liang T, Zhang YF.
    Ai Zheng; 2005 Mar; 24(3):268-72. PubMed ID: 15757525
    [Abstract] [Full Text] [Related]

  • 23. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
    Zhu DE, Höti N, Song Z, Jin L, Wu Z, Wu Q, Wu M.
    Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
    [Abstract] [Full Text] [Related]

  • 24. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 25. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
    Yamaguchi Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Saitou Y, Sugimoto K, Nakano T.
    Oncol Rep; 2005 Nov 15; 14(5):1311-6. PubMed ID: 16211302
    [Abstract] [Full Text] [Related]

  • 26. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y, Nishiguchi S, Tamori A, Koh N, Yano Y, Kubo S, Hirohashi K, Otani S.
    Clin Cancer Res; 2001 May 15; 7(5):1293-8. PubMed ID: 11350897
    [Abstract] [Full Text] [Related]

  • 27. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
    Croci DO, Cogno IS, Vittar NB, Salvatierra E, Trajtenberg F, Podhajcer OL, Osinaga E, Rabinovich GA, Rivarola VA.
    J Cell Biochem; 2008 Oct 01; 105(2):381-90. PubMed ID: 18553460
    [Abstract] [Full Text] [Related]

  • 28. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG.
    Cancer Res; 2008 May 01; 68(9):3152-60. PubMed ID: 18451140
    [Abstract] [Full Text] [Related]

  • 29. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA, Niu MY, Renart LI.
    Apoptosis; 2006 Apr 01; 11(4):589-605. PubMed ID: 16528475
    [Abstract] [Full Text] [Related]

  • 30. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
    Lee SH, Kim JW, Oh SH, Kim YJ, Rho SB, Park K, Park KL, Lee JH.
    FEBS Lett; 2005 Feb 14; 579(5):1027-33. PubMed ID: 15710386
    [Abstract] [Full Text] [Related]

  • 31. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W, Bisi J, Strum J, Liu L, Carrick K, Graham KM, Treece AL, Hardwicke MA, Dush M, Liao Q, Westlund RE, Zhao S, Bacus S, Spector NL.
    Cancer Res; 2006 Feb 01; 66(3):1640-7. PubMed ID: 16452223
    [Abstract] [Full Text] [Related]

  • 32. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

  • 33. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov 01; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

  • 34. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.
    Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M, Curley SA, Yu Y, Hunt KK, Fang B.
    Oncogene; 2002 Nov 14; 21(52):8020-8. PubMed ID: 12439752
    [Abstract] [Full Text] [Related]

  • 35. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
    Suh YJ, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK.
    Surgery; 2005 Sep 14; 138(3):422-30. PubMed ID: 16213894
    [Abstract] [Full Text] [Related]

  • 36. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb 14; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 37. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR, Bell S, Tenev T, Stoll V, Lopes R, Lemoine NR, McNeish IA.
    Oncogene; 2003 Jun 05; 22(23):3539-47. PubMed ID: 12789262
    [Abstract] [Full Text] [Related]

  • 38. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F, Boidot R, Oudin C, Defrain C, Rebucci M, Lizard-Nacol S.
    Oncogene; 2007 Jan 11; 26(2):290-7. PubMed ID: 16847456
    [Abstract] [Full Text] [Related]

  • 39. Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors.
    Egwuagu CE, Li W, Yu CR, Che Mei Lin M, Chan CC, Nakamura T, Chepelinsky AB.
    Oncogene; 2006 Jun 22; 25(26):3670-9. PubMed ID: 16462767
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.